17.19
Finanzdaten der Pulse Biosciences Inc-Aktie (PLSE)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
-
|
- | - | - | - |
Research and Development |
13.57%
6.741
|
7.799 | 7.472 | 6.697 | 5.829 |
Costs And Expenses |
15.30%
10.62
|
12.53 | 11.25 | 10.23 | 9.562 |
Operating Income/Loss |
15.30%
-10.62
|
-12.53 | -11.25 | -10.23 | -9.562 |
Nonoperating Income/Loss |
20.33%
0.478
|
0.60 | 0.686 | 0.317 | -0.239 |
Income/Loss From Continuing Operations Before Tax |
15.05%
-10.14
|
-11.93 | -10.57 | -9.91 | -9.801 |
Income Tax Expense/Benefit |
-
|
- | - | - | - |
Income/Loss From Continuing Operations After Tax |
15.05%
-10.14
|
-11.93 | -10.57 | -9.91 | -9.801 |
|
15.05%
-10.14
|
-11.93 | -10.57 | -9.91 | -9.801 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
2,232%
55.17
|
2.366 | 54.92 | 44.51 | 37.39 |
Basic Earnings Per Share |
18.18%
-0.18
|
-0.22 | -0.19 | -0.22 | -0.26 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):